Adjunctive treatment with high-titre convalescent plasma in severely and critically ill COVID-19 patients - a safe but futile intervention. A comparative cohort study.
Wolfgang Paul HoeplerLisa WeidnerMarianna Theresia TraugottStephanie NeuholdElias Laurin MeyerAlexander ZoufalyTamara SeitzReinhard KitzbergerSebastian BaumgartnerErich PawelkaMario KarolyiAlexander ZoufalyJulian HindHermann LaferlEmanuela FrieseChristoph WenischStephan Walter AberleJudith Helene AberleLukas WeseslindtnerChristoph JungbauerPublished in: Infectious diseases (London, England) (2021)
While adjunctive treatment with CP for severe and life-threatening COVID-19 was a very safe intervention, we did not observe any effect on mortality.